These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 9389918
21. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients. Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X. Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775 [Abstract] [Full Text] [Related]
22. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer. Reale MG, Santini D, Marchei GG, Manna A, Del Nero A, Bianco V, Marchei P, Frati L. Int J Biol Markers; 1995 Nov 15; 10(1):42-6. PubMed ID: 7629426 [Abstract] [Full Text] [Related]
23. Serum bone alkaline phosphatase in the follow-up of skeletal metastases. Zaninotto M, Secchiero S, Rubin D, Sciacovelli L, Trovò M, Bortolus R, Plebani M. Anticancer Res; 1995 Nov 15; 15(5B):2223-8. PubMed ID: 8572629 [Abstract] [Full Text] [Related]
24. Changes of bone metabolic markers in patients with bone metastases: clinical significance in assessing bone response to chemotherapy. Wada S, Katayama Y, Yasutomo Y, Kugai N, Nagata N. Intern Med; 1993 Aug 15; 32(8):611-8. PubMed ID: 8312657 [Abstract] [Full Text] [Related]
25. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F. Nephrol Dial Transplant; 1998 Sep 15; 13(9):2294-302. PubMed ID: 9761512 [Abstract] [Full Text] [Related]
26. Osteocalcin: a potential marker of metastatic bone disease and response to treatment. Coleman RE, Mashiter G, Fogelman I, Whitaker KD, Caleffi M, Moss DW, Rubens RD. Eur J Cancer Clin Oncol; 1988 Jul 15; 24(7):1211-7. PubMed ID: 3262063 [Abstract] [Full Text] [Related]
27. Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumour type. Body JJ, Dumon JC. Ann Oncol; 1994 Apr 15; 5(4):359-63. PubMed ID: 8075034 [Abstract] [Full Text] [Related]
28. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis. Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Kitazono T. Clin Endocrinol (Oxf); 2013 Jun 15; 78(6):844-51. PubMed ID: 23078546 [Abstract] [Full Text] [Related]
29. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies. Azinge EC, Bolarin DM. Niger J Physiol Sci; 2006 Jun 15; 21(1-2):21-5. PubMed ID: 17242729 [Abstract] [Full Text] [Related]
30. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report]. Casetta G, Gamba P, Piana P, Pecchio F, Tizzani A. Minerva Urol Nefrol; 1995 Mar 15; 47(1):9-12. PubMed ID: 7570264 [Abstract] [Full Text] [Related]
31. [Correlation of the levels of the bone turnover markers BAP and β-CTX with bone metastasis progress in lung cancer patients]. Tang Q, Zhao H, Jia R, Liu L. Zhongguo Fei Ai Za Zhi; 2013 Mar 15; 16(3):144-7. PubMed ID: 23514943 [Abstract] [Full Text] [Related]
32. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study. Beyeler C, Banks R, Thompson D, Forbes MA, Cooper EH, Bird HA. J Rheumatol; 1996 Feb 15; 23(2):241-4. PubMed ID: 8882026 [Abstract] [Full Text] [Related]
33. Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects. Catherwood BD, Marcus R, Madvig P, Cheung AK. Bone; 1985 Feb 15; 6(1):9-13. PubMed ID: 3873250 [Abstract] [Full Text] [Related]
34. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase. Broyles DL, Nielsen RG, Bussett EM, Lu WD, Mizrahi IA, Nunnelly PA, Ngo TA, Noell J, Christenson RH, Kress BC. Clin Chem; 1998 Oct 15; 44(10):2139-47. PubMed ID: 9761247 [Abstract] [Full Text] [Related]
35. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Gomez B, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT. Clin Chem; 1995 Nov 15; 41(11):1560-6. PubMed ID: 7586543 [Abstract] [Full Text] [Related]
36. Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension. Berruti A, Piovesan A, Torta M, Raucci CA, Gorzegno G, Paccotti P, Dogliotti L, Angeli A. Br J Cancer; 1996 Jun 15; 73(12):1581-7. PubMed ID: 8664134 [Abstract] [Full Text] [Related]
37. Usefulness of bone formation markers in breast cancer. Palma MA, Body JJ. Int J Biol Markers; 2005 Jun 15; 20(3):146-55. PubMed ID: 16240842 [Abstract] [Full Text] [Related]
38. Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover. Mukaiyama K, Kamimura M, Uchiyama S, Ikegami S, Nakamura Y, Kato H. Aging Clin Exp Res; 2015 Aug 15; 27(4):413-8. PubMed ID: 25534961 [Abstract] [Full Text] [Related]
39. Behavior of bone alkaline phosphatase (BAP) determined with immunoradiometric assay in metastatic prostate cancer. Lorente JA, Morote J. Int J Biol Markers; 1994 Aug 15; 9(3):145. PubMed ID: 7530275 [No Abstract] [Full Text] [Related]
40. Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. Burlina A, Rubin D, Secchiero S, Sciacovelli L, Zaninotto M, Plebani M. Clin Chim Acta; 1994 May 15; 226(2):151-8. PubMed ID: 7923810 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]